$QNCX
Quince Therapeutics, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022023877 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.550M $4.340M $9.060M
YoY Change -57.38% -43.19% 28.33%
% of Gross Profit
Research & Development $2.770M $2.451M $7.199M
YoY Change -81.79% -82.54% -51.09%
% of Gross Profit
Depreciation & Amortization $40.00K $40.00K $80.00K
YoY Change -50.0% -55.56% 0.0%
% of Gross Profit
Operating Expenses $6.320M $7.620M $16.26M
YoY Change -73.15% -64.85% -25.36%
Operating Profit -$7.620M -$16.26M
YoY Change -64.85% -25.36%
Interest Expense $540.0K $320.0K $150.0K
YoY Change 390.91% 146.15% -6.25%
% of Operating Profit
Other Income/Expense, Net $250.0K -$616.0K -$735.0K
YoY Change 525.0% 292.36% 461.07%
Pretax Income -$5.530M -$7.920M -$16.85M
YoY Change -76.37% -63.52% -22.53%
Income Tax $0.00 $0.00 -$284.0K
% Of Pretax Income
Net Earnings -$5.530M -$7.921M -$16.56M
YoY Change -76.37% -63.51% -23.86%
Net Earnings / Revenue
Basic Earnings Per Share -$0.22 -$0.51
Diluted Earnings Per Share -$0.15 -$0.22 -$0.51
COMMON SHARES
Basic Shares Outstanding 36.13M 35.61M 30.15M
Diluted Shares Outstanding 35.61M 32.47M

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.18M $84.11M $94.70M
YoY Change 35.55% -26.48% -27.13%
Cash & Equivalents $44.58M $21.58M $46.93M
Short-Term Investments $45.60M $62.53M $54.80M
Other Short-Term Assets $276.0K $336.0K $4.800M
YoY Change -24.8% -32.12% 995.89%
Inventory
Prepaid Expenses $223.0K $270.0K
Receivables
Other Receivables
Total Short-Term Assets $93.75M $98.28M $99.40M
YoY Change -16.05% -17.71% -26.83%
LONG-TERM ASSETS
Property, Plant & Equipment $393.0K $375.0K $700.0K
YoY Change 49.43% 23.76% 79.49%
Goodwill $0.00 $0.00 $825.0K
YoY Change
Intangibles $5.900M $5.900M
YoY Change
Long-Term Investments $3.600M $5.000M $11.00M
YoY Change -81.91% -80.84% -53.19%
Other Assets $0.00 $17.00K $0.00
YoY Change -100.0% -91.19% -100.0%
Total Long-Term Assets $10.16M $11.50M $18.50M
YoY Change -52.86% -58.91% -27.58%
TOTAL ASSETS
Total Short-Term Assets $93.75M $98.28M $99.40M
Total Long-Term Assets $10.16M $11.50M $18.50M
Total Assets $103.9M $109.8M $117.9M
YoY Change -22.01% -25.53% -26.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $570.0K $1.181M $1.900M
YoY Change -88.39% -58.99% -73.59%
Accrued Expenses $2.499M $3.764M $4.000M
YoY Change -73.16% -66.61% -64.74%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $100.0K
YoY Change
Total Short-Term Liabilities $3.069M $4.945M $6.000M
YoY Change -78.42% -65.06% -67.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% -87.5%
Total Long-Term Liabilities $0.00 $0.00 $100.0K
YoY Change -100.0% -100.0% -87.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.069M $4.945M $6.000M
Total Long-Term Liabilities $0.00 $0.00 $100.0K
Total Liabilities $3.317M $5.246M $6.300M
YoY Change -77.35% -64.47% -67.37%
SHAREHOLDERS EQUITY
Retained Earnings -$288.3M -$282.7M
YoY Change 21.85% 32.6%
Common Stock $389.1M $387.5M
YoY Change 9.54% 12.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $100.6M $104.5M $111.5M
YoY Change
Total Liabilities & Shareholders Equity $103.9M $109.8M $117.9M
YoY Change -22.01% -25.53% -26.95%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$5.530M -$7.921M -$16.56M
YoY Change -76.37% -63.51% -23.86%
Depreciation, Depletion And Amortization $40.00K $40.00K $80.00K
YoY Change -50.0% -55.56% 0.0%
Cash From Operating Activities -$5.840M -$6.690M -$15.42M
YoY Change -59.5% -61.42% -12.19%
INVESTING ACTIVITIES
Capital Expenditures $70.00K $50.00K $0.00
YoY Change 75.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $18.75M -$8.780M -$5.250M
YoY Change -10.54% -1240.26% -191.78%
Cash From Investing Activities $18.66M -$8.820M -$5.250M
YoY Change -10.8% -1260.53% -193.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K 0.000 110.0K
YoY Change -102.02% -100.0% -83.58%
NET CHANGE
Cash From Operating Activities -5.840M -6.690M -15.42M
Cash From Investing Activities 18.66M -8.820M -5.250M
Cash From Financing Activities -20.00K 0.000 110.0K
Net Change In Cash 12.80M -15.51M -20.56M
YoY Change 70.89% 30.67% 82.59%
FREE CASH FLOW
Cash From Operating Activities -$5.840M -$6.690M -$15.42M
Capital Expenditures $70.00K $50.00K $0.00
Free Cash Flow -$5.910M -$6.740M -$15.42M
YoY Change -59.13% -61.13% -12.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-38890
dei Entity Registrant Name
EntityRegistrantName
Quince Therapeutics, Inc.
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2019Q2 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
dei Amendment Flag
AmendmentFlag
false
qncx Entity Date Of Incorporation
EntityDateOfIncorporation
2012-06
dei Entity Central Index Key
EntityCentralIndexKey
0001662774
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q2 qncx Operating Lease Termination Month And Year
OperatingLeaseTerminationMonthAndYear
2021-07
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1024039
dei Entity Address Address Line1
EntityAddressAddressLine1
601 Gateway Boulevard, Suite 1250.
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
910-5717
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-284000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
248000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2022Q3 us-gaap Liabilities
Liabilities
5246000
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36130306
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31809000
CY2021Q4 us-gaap Liabilities
Liabilities
14642000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
QNCX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
420000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36130306
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69724000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
62534000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
37078000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3933000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4871000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
98276000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
111673000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
375000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
263000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
208000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1165000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
5001000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
19933000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5900000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
194000
CY2022Q3 us-gaap Assets
Assets
109777000
CY2021Q4 us-gaap Assets
Assets
133228000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1181000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4911000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3764000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9311000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4945000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14222000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
19000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36130306
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21677000
us-gaap Operating Income Loss
OperatingIncomeLoss
-45696000
us-gaap Operating Income Loss
OperatingIncomeLoss
-66774000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
315000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30074412
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30074412
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
36000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
30000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
387473000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
355234000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-253000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-79000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-282725000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-236599000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
104531000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
118586000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
109777000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133228000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2451000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14038000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22410000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45582000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4344000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7639000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22461000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21192000
CY2022Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
825000
CY2021Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
825000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7620000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
21677000
us-gaap Operating Expenses
OperatingExpenses
45696000
us-gaap Operating Expenses
OperatingExpenses
66774000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7620000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
128000
us-gaap Investment Income Interest
InvestmentIncomeInterest
532000
us-gaap Investment Income Interest
InvestmentIncomeInterest
515000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-616000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-157000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1246000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-287000
CY2022Q3 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-7921000
CY2021Q3 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-21706000
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-46410000
us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-66546000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-664000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
608000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7921000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-21706000
us-gaap Net Income Loss
NetIncomeLoss
-46126000
us-gaap Net Income Loss
NetIncomeLoss
-66546000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
343000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
481000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-130000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-64000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-655000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-260000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7708000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21752000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46300000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66788000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.73
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.25
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.25
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35612749
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35612749
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29767376
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29767376
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32758132
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32758132
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29637328
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29637328
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
111532000
CY2022Q3 qncx Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
13000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
694000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
343000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-130000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-7921000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
104531000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
142080000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4706000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7618000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-64000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-21706000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
132652000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
118586000
qncx Share Based Compensation Arrangement By Share Based Payment Award Value Options And Non Option Equity Instruments Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOptionsAndNonOptionEquityInstrumentsExercisesInPeriod
148000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14986000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-175000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
154000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5329000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-675000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5304000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2664000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38203000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
16503000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
481000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-655000
us-gaap Net Income Loss
NetIncomeLoss
-46126000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
104531000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
172262000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5818000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21360000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-260000
us-gaap Net Income Loss
NetIncomeLoss
-66546000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
132652000
us-gaap Profit Loss
ProfitLoss
-46126000
us-gaap Profit Loss
ProfitLoss
-66546000
qncx Non Cash Rent Expense
NonCashRentExpense
0
qncx Non Cash Rent Expense
NonCashRentExpense
199000
us-gaap Share Based Compensation
ShareBasedCompensation
14986000
us-gaap Share Based Compensation
ShareBasedCompensation
21360000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
162000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
260000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
136000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
qncx Loss On Disposal
LossOnDisposal
77000
qncx Loss On Disposal
LossOnDisposal
0
qncx Non Cash Goodwill Impairment Charge
NonCashGoodwillImpairmentCharge
825000
qncx Non Cash Goodwill Impairment Charge
NonCashGoodwillImpairmentCharge
0
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-83000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-679000
qncx Change In Deferred Tax Liabilities Due To Acquisition
ChangeInDeferredTaxLiabilitiesDueToAcquisition
284000
qncx Change In Deferred Tax Liabilities Due To Acquisition
ChangeInDeferredTaxLiabilitiesDueToAcquisition
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2396000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
973000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48514000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
66767000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
35778000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
55495000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
73947000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
10593000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
70000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
55000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
62534000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
5001000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
38033000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
31000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
148000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5818000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
608000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
725000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5818000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37915000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4634000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69724000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66841000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31809000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62207000
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
16503000
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0
qncx Right Of Use Asset Obtained In Exchange For Operating Lease Liabilities1
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilities1
256000
qncx Right Of Use Asset Obtained In Exchange For Operating Lease Liabilities1
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilities1
1254000
qncx Right Of Use Asset And Operating Lease Liability Reduction As A Result Of Lease Modification
RightOfUseAssetAndOperatingLeaseLiabilityReductionAsAResultOfLeaseModification
-640000
qncx Right Of Use Asset And Operating Lease Liability Reduction As A Result Of Lease Modification
RightOfUseAssetAndOperatingLeaseLiabilityReductionAsAResultOfLeaseModification
0
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-282700000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
94300000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
5000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:8.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">he preparation of the Company’s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses, as well as related disclosure of contingent assets and liabilities. The most significant estimates used in the Company’s consolidated financial statements relate to the determination of the fair value of stock-based awards and other issuances, determination of the fair value of identifiable assets and liabilities in connection with the acquisition of Novosteo, Inc., including associated intangible assets and goodwill, accruals for research and development costs, useful lives of long-lived assets, stock-based compensation and related assumptions, the incremental borrowing rate for leases and income tax uncertainties, including a valuation allowance for deferred tax assets, eligibility of expenses for the Australia research and development refundable tax credits; and contingencies. The Company bases its estimates on historical experience and on various other market specific and other relevant assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ materially from the Company’s estimates.</span></p>
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
754000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
89111000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21576000
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
89111000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
86465000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
89864000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
89111000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
86564000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
18000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
117000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
86465000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29454000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
37078000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
19933000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
86465000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2022Q3 qncx Available For Sale Securities Gross Realized Gains Or Losses
AvailableForSaleSecuritiesGrossRealizedGainsOrLosses
0
qncx Available For Sale Securities Gross Realized Gains Or Losses
AvailableForSaleSecuritiesGrossRealizedGainsOrLosses
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q3 qncx Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2021Q4 qncx Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2022Q3 qncx Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2021Q4 qncx Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2022Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
31809000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
69724000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
62534000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
37078000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
5001000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
19933000
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
270000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
333000
CY2022Q3 qncx Prepaid Insurance Current
PrepaidInsuranceCurrent
1356000
CY2021Q4 qncx Prepaid Insurance Current
PrepaidInsuranceCurrent
1144000
CY2022Q3 qncx Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
929000
CY2021Q4 qncx Prepaid Research And Development Expenses Current
PrepaidResearchAndDevelopmentExpensesCurrent
1899000
CY2022Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
1042000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
1128000
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
336000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
367000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3933000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4871000
CY2022Q3 qncx Reductions In Research And Development Expense
ReductionsInResearchAndDevelopmentExpense
100000
qncx Reductions In Research And Development Expense
ReductionsInResearchAndDevelopmentExpense
500000
CY2021Q3 qncx Reductions In Research And Development Expense
ReductionsInResearchAndDevelopmentExpense
0
qncx Reductions In Research And Development Expense
ReductionsInResearchAndDevelopmentExpense
0
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
159000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
959000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
375000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
263000
CY2022Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
804000
CY2021Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
820000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
278000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
462000
CY2022Q3 qncx Director And Officer Insurance
DirectorAndOfficerInsurance
1386000
CY2021Q4 qncx Director And Officer Insurance
DirectorAndOfficerInsurance
0
CY2022Q3 qncx Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
800000
CY2021Q4 qncx Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
7108000
CY2022Q3 qncx Accrued Operating Lease Liabilities Current
AccruedOperatingLeaseLiabilitiesCurrent
292000
CY2021Q4 qncx Accrued Operating Lease Liabilities Current
AccruedOperatingLeaseLiabilitiesCurrent
741000
CY2022Q3 qncx Accrued Finance Lease Liabilities Current
AccruedFinanceLeaseLiabilitiesCurrent
75000
CY2021Q4 qncx Accrued Finance Lease Liabilities Current
AccruedFinanceLeaseLiabilitiesCurrent
0
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
129000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
180000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3764000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9311000
CY2021Q4 qncx Accrued Severance
AccruedSeverance
0
qncx Accrued Severance Incurred
AccruedSeveranceIncurred
3942000
qncx Accrued Severance Paid
AccruedSeverancePaid
-3942000
CY2022Q3 qncx Accrued Severance
AccruedSeverance
0
CY2018Q2 qncx Number Of Investors
NumberOfInvestors
1
CY2018Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2018Q2 qncx Repurchase Option Percentage
RepurchaseOptionPercentage
1
CY2018Q2 qncx Operating Leases Period
OperatingLeasesPeriod
P3Y
CY2019Q2 qncx Operating Lease Payments Paid For Additional Space
OperatingLeasePaymentsPaidForAdditionalSpace
63000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
0
CY2020Q2 qncx Operating Lease Termination Month And Year
OperatingLeaseTerminationMonthAndYear
2021-07
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
172000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
172000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1200000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
CY2022Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P1Y
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
640000000
qncx Payments For Security Deposit
PaymentsForSecurityDeposit
105000
qncx Operating Lease Future Rent Expense
OperatingLeaseFutureRentExpense
218000000
qncx Finance Lease Amortized Period On Equipment Service
FinanceLeaseAmortizedPeriodOnEquipmentService
P18M
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
31000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
208000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1165000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
292000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
741000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
420000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
326000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1161000
CY2022Q3 qncx Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
124000
CY2021Q4 qncx Finance Lease Right Of Use Asset Gross
FinanceLeaseRightOfUseAssetGross
557000
CY2022Q3 qncx Accumulated Amortization Of Finance Lease
AccumulatedAmortizationOfFinanceLease
31000
CY2021Q4 qncx Accumulated Amortization Of Finance Lease
AccumulatedAmortizationOfFinanceLease
557000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
93000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0514
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0187
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0445
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
80000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
757000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
256000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
422000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
336000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1179000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
326000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1161000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7100
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y5M19D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Share Based Liabilities Paid
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsShareBasedLiabilitiesPaid
3600000
CY2022Q1 qncx Lifetodateexpense
Lifetodateexpense
1600000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
694000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7618000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14986000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21360000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5692442
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.006
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9038850
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
10593000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
1040000
CY2022Q2 qncx Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Right Of Use Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
124000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
279000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
5900000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
1726000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
532000
CY2022Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
15678000
CY2022Q2 us-gaap Goodwill
Goodwill
825000
CY2022Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
0
CY2021Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
3000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
262000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
223000
CY2022Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-7921000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-22478000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-47057000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-71046000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2200000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
5900000
CY2022Q2 us-gaap Goodwill
Goodwill
825000
CY2022Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
825000
CY2022Q3 us-gaap Goodwill
Goodwill
0
CY2022Q3 qncx Non Cash Goodwill Impairment Charge
NonCashGoodwillImpairmentCharge
800000

Files In Submission

Name View Source Status
0000950170-22-023877-index-headers.html Edgar Link pending
0000950170-22-023877-index.html Edgar Link pending
0000950170-22-023877.txt Edgar Link pending
0000950170-22-023877-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qncx-20220930.htm Edgar Link pending
qncx-20220930.xsd Edgar Link pending
qncx-ex10_1.htm Edgar Link pending
qncx-ex31_1.htm Edgar Link pending
qncx-ex31_2.htm Edgar Link pending
qncx-ex32_1.htm Edgar Link pending
qncx-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qncx-20220930_cal.xml Edgar Link unprocessable
qncx-20220930_def.xml Edgar Link unprocessable
qncx-20220930_pre.xml Edgar Link unprocessable
qncx-20220930_lab.xml Edgar Link unprocessable
qncx-20220930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending